462
Views
17
CrossRef citations to date
0
Altmetric
Original Article

The utility of 25-question Geriatric Locomotive Function Scale for evaluating functional ability and disease activity in Japanese rheumatoid arthritis patients: A cross-sectional study using NinJa database

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 328-334 | Received 25 Sep 2017, Accepted 14 Mar 2018, Published online: 18 Apr 2018

References

  • McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205–19.
  • Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet. 2007;370:1861–74.
  • Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388:2023–38.
  • Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376:1094–108.
  • Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23:137–45.
  • Pincus T, Summey JA, Soraci SA Jr., Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 1983;26:1346–53.
  • Ramey DR, Raynauld JP, Fries JF. The health assessment questionnaire 1992: status and review. Arthritis Care Res. 1992;5:119–29.
  • van der Heijde DM, van Riel PL, van de Putte LB. Sensitivity of a Dutch health assessment questionnaire in a trial comparing hydroxychloroquine vs. sulphasalazine. Scand J Rheumatol. 1990;19:407–12.
  • Ono K, Ohashi S, Oka H, Kadono Y, Yasui T, Omata Y, et al. The impact of joint disease on the modified health assessment questionnaire scores in rheumatoid arthritis patients: a cross-sectional study using the national database of rheumatic diseases by iR-net in Japan. Mod Rheumatol. 2016;26:529–33.
  • Sokka T, Kankainen A, Hannonen P. Scores for functional disability in patients with rheumatoid arthritis are correlated at higher levels with pain scores than with radiographic scores. Arthritis Rheum. 2000;43:386–9.
  • Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum. 2001;44:2009–17.
  • Akai M, Doi T, Seichi A, Okuma Y, Ogata T, Iwaya T. Locomotive syndrome: operational definition based on a questionnaire, and exercise interventions on mobility dysfunction in elderly people. Clinic Rev Bone Miner Metab. 2016;14:119–30.
  • Nakamura K. A “super-aged” society and the “locomotive syndrome”. J Orthop Sci. 2008;13:1–2.
  • Seichi A, Hoshino Y, Doi T, Akai M, Tobimatsu Y, Iwaya T. Development of a screening tool for risk of locomotive syndrome in the elderly: the 25-question geriatric locomotive function scale. J Orthop Sci. 2012;17:163–72.
  • Kimura A, Seichi A, Konno S, Yabuki S, Hayashi K. Prevalence of locomotive syndrome in Japan: a nationwide, cross-sectional Internet survey. J Orthop Sci. 2014;19:792–7.
  • Seichi A, Kimura A, Konno S, Yabuki S. Epidemiologic survey of locomotive syndrome in Japan. J Orthop Sci. 2016;21:222–5.
  • Yoshimura N, Muraki S, Nakamura K, Tanaka S. Epidemiology of the locomotive syndrome: the research on osteoarthritis/osteoporosis against disability study 2005-2015. Mod Rheumatol. 2017;27:1–7.
  • Yoshimura N, Muraki S, Oka H, Tanaka S, Ogata T, Kawaguchi H, et al. Association between new indices in the locomotive syndrome risk test and decline in mobility: third survey of the ROAD study. J Orthop Sci. 2015;20:896–905.
  • Sokka T, Kautiainen H, Hannonen P, Pincus T. Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population. Arthritis Rheum. 2006;54:3113–18.
  • Yamanaka H, Tohma S. Potential impact of observational cohort studies in Japan on rheumatoid arthritis research and practice. Mod Rheumatol. 2006;16:75–6.
  • Nakamura K, Ogata T. Locomotive syndrome: definition and management. Clin Rev Bone Miner Metab. 2016;14:56–67.
  • Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44–8.
  • Akaike H. Information Theory and an Extension of the Maximum Likelihood Principle. Budapest (Hungary): Akademia Kiado; 1973.
  • Iwata S, Uehara K, Ogura K, Akiyama T, Shinoda Y, Yonemoto T, et al. Reliability and validity of a Japanese-language and culturally adapted version of the musculoskeletal tumor society scoring system for the lower extremity. Clin Orthop Relat Res. 2016;474:2044–52.
  • Nagao M, Doi T, Saita Y, Kobayashi Y, Kubota M, Kaneko H, et al. A novel patient-reported outcome measure for anterior cruciate ligament injury: evaluating the reliability, validity, and responsiveness of Japanese anterior cruciate ligament questionnaire. Knee Surg Sports Traumatol Arthrosc. 2016;24:2973–82.
  • Iwaya T, Doi T, Seichi A, Hoshino Y, Ogata T, Akai M. Characteristics of disability in activity of daily living in elderly people associated with locomotive disorders. BMC Geriatr. 2017;17:165.
  • Bazzani C, Filippini M, Caporali R, Bobbio-Pallavicini F, Favalli EG, Marchesoni A, et al. Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: clinical outcomes. Autoimmun Rev. 2009;8:260–5.
  • Haugeberg G, Boyesen P, Helgetveit K, Proven A. Clinical and radiographic outcomes in patients diagnosed with early rheumatoid arthritis in the first years of the biologic treatment era: a 10-year prospective observational study. J Rheumatol. 2015;42:2279–87.
  • Kievit W, Adang EM, Fransen J, Kuper HH, van de Laar MA, Jansen TL, et al. The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice data. Ann Rheum Dis. 2008;67:1229–34.
  • Miwa Y, Saito M, Furuya H, Yanai R, Ikari Y, Hayashi T, et al. Clinical characteristics of rheumatoid arthritis patients achieving functional remission after six months of non-tumor necrosis factor biological Disease-Modifying Antirheumatic Drugs (DMARDs) treatment. Intern Med. 2017;56:903–6.
  • Nam JL, Takase-Minegishi K, Ramiro S, Chatzidionysiou K, Smolen JS, van der Heijde D, et al. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2017;76:1113–36.
  • Yasui T, Nishino J, Kadono Y, Matsui T, Nakamura K, Tanaka S, et al. Impact of biologics on the prevalence of orthopedic surgery in the National Database of Rheumatic Diseases in Japan. Mod Rheumatol. 2010;20:233–7.
  • Chiba D, Tsuda E, Wada K, Kumagai G, Sasaki E, Nawata A, et al. Lumbar spondylosis, lumbar spinal stenosis, knee pain, back muscle strength are associated with the locomotive syndrome: rural population study in Japan. J Orthop Sci. 2016;21:366–72.
  • Hirano K, Imagama S, Hasegawa Y, Ito Z, Muramoto A, Ishiguro N. The influence of locomotive syndrome on health-related quality of life in a community-living population. Mod Rheumatol. 2013;23:939–44.
  • Hirano K, Imagama S, Hasegawa Y, Ito Z, Muramoto A, Ishiguro N. Impact of low back pain, knee pain, and timed up-and-go test on quality of life in community-living people. J Orthop Sci. 2014;19:164–71.
  • Hirano K, Imagama S, Hasegawa Y, Wakao N, Muramoto A, Ishiguro N. Impact of spinal imbalance and back muscle strength on locomotive syndrome in community-living elderly people. J Orthop Sci. 2012;17:532–7.
  • Hirano K, Imagama S, Hasegawa Y, Wakao N, Muramoto A, Ishiguro N. Impact of back muscle strength and aging on locomotive syndrome in community living Japanese women. Nagoya J Med Sci. 2013;75:47–55.
  • Iizuka Y, Iizuka H, Mieda T, Tajika T, Yamamoto A, Takagishi K. Population-based study of the association of osteoporosis and chronic musculoskeletal pain and locomotive syndrome: the Katashina study. J Orthop Sci. 2015;20:1085–9.
  • Ikemoto T, Inoue M, Nakata M, Miyagawa H, Shimo K, Wakabayashi T, et al. Locomotive syndrome is associated not only with physical capacity but also degree of depression. J Orthop Sci. 2016;21:361–5.
  • Muramoto A, Imagama S, Ito Z, Hirano K, Ishiguro N, Hasegawa Y. Spinal sagittal balance substantially influences locomotive syndrome and physical performance in community-living middle-aged and elderly women. J Orthop Sci. 2016;21:216–21.
  • Muramoto A, Imagama S, Ito Z, Hirano K, Tauchi R, Ishiguro N, et al. Waist circumference is associated with locomotive syndrome in elderly females. J Orthop Sci. 2014;19:612–19.
  • Nakamura M, Kobashi Y, Hashizume H, Oka H, Kono R, Nomura S, et al. Locomotive syndrome is associated with body composition and cardiometabolic disorders in elderly Japanese women. BMC Geriatr. 2016;16:166.
  • Otani K, Takegami M, Fukumori N, Sekiguchi M, Onishi Y, Yamazaki S, et al. Locomotor dysfunction and risk of cardiovascular disease, quality of life, and medical costs: design of the Locomotive Syndrome and Health Outcome in Aizu Cohort Study (LOHAS) and baseline characteristics of the study population. J Orthop Sci. 2012;17:261–71.
  • Iwaya T, Doi T, Seichi A, Hoshino Y, Ogata T, Akai M. Relationship between physician-judged functioning level and self-reported disabilities in elderly people with locomotive disorders. Qual Life Res. 2017;26:35–43.
  • Andersson MLE, Forslind K, Hafstrom I, Group BS. Patients with early rheumatoid arthritis in the 2000s Have equal disability and pain despite less disease activity compared with the 1990s: data from the BARFOT study over 8 years. J Rheumatol. 2017;44:723–31.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.